Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
SCHW
|
Peter J. Morgan Iii
General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct | 1,677 Reduced 12.37% |
$70,082
$41.79 p/Share
|
Nov 02
2020 |
AMGN
|
Ellen Jamison Kullman
Director |
BUY
Grant, award, or other acquisition
|
Direct | 140 Added 2.0% |
-
|
Nov 02
2020 |
AMGN
|
Murdo Gordon
EVP, Global Commercial Ops |
SELL
Payment of exercise price or tax liability
|
Direct | 6,269 Reduced 16.37% |
$1,359,997
$216.94 p/Share
|
Nov 02
2020 |
AMGN
|
Linda H. Louie
VP, Finance & CAO |
BUY
Grant, award, or other acquisition
|
Direct | 1,453 Added 15.99% |
-
|
Nov 02
2020 |
AMGN
|
David M Reese
EVP & Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 2,125 Reduced 5.09% |
$460,998
$216.94 p/Share
|
Nov 02
2020 |
TMO
|
Marc N Casper
Chairman & CEO |
SELL
Open market or private sale
|
Indirect | 15,000 Reduced 21.64% |
$7,261,350
$484.09 p/Share
|
Nov 02
2020 |
KO
|
John Murphy
President and CFO |
SELL
Open market or private sale
|
Direct | 112,400 Reduced 43.47% |
$5,482,872
$48.78 p/Share
|
Nov 02
2020 |
KO
|
John Murphy
President and CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 112,400 Added 30.3% |
$3,596,800
$32.0 p/Share
|
Nov 02
2020 |
MA
|
Foundation Mastercard |
SELL
Open market or private sale
|
Direct | 30,100 Reduced 0.03% |
$8,798,230
$292.3 p/Share
|
Nov 02
2020 |
ARES
|
David B Kaplan
Co-Founder |
SELL
Open market or private sale
|
Indirect | 103,002 Reduced 7.61% |
$4,399,215
$42.71 p/Share
|
Nov 02
2020 |
FDX
|
Robert B Carter
EVP / Chief Info Officer |
SELL
Open market or private sale
|
Indirect | 750 Reduced 24.37% |
$195,900
$261.2 p/Share
|
Nov 02
2020 |
AYI
|
James H Hance Jr
Director |
BUY
Grant, award, or other acquisition
|
Direct | 400 Added 2.78% |
$36,284
$90.71 p/Share
|
Nov 02
2020 |
AYI
|
Robert F Mccullough
Director |
BUY
Grant, award, or other acquisition
|
Direct | 400 Added 5.4% |
$36,284
$90.71 p/Share
|
Nov 02
2020 |
AYI
|
Ray M Robinson
Director |
BUY
Grant, award, or other acquisition
|
Direct | 400 Added 10.35% |
$36,284
$90.71 p/Share
|
Nov 02
2020 |
AYI
|
Mary A Winston
Director |
BUY
Grant, award, or other acquisition
|
Direct | 400 Added 16.46% |
$36,284
$90.71 p/Share
|
Nov 02
2020 |
EA
|
Jeff Huber
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 172 Added 0.2% |
$20,607
$119.81 p/Share
|
Nov 02
2020 |
EA
|
Roche L Talbott Hoskins
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 172 Added 1.2% |
$20,607
$119.81 p/Share
|
Nov 02
2020 |
EA
|
Richard A Simonson
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 206 Added 0.47% |
$24,681
$119.81 p/Share
|
Nov 02
2020 |
EA
|
Jay C Hoag
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 196 Added 35.25% |
$23,483
$119.81 p/Share
|
Nov 02
2020 |
SPOK
|
Todd J Stein |
BUY
Open market or private purchase
|
Direct | 0 Added 0.0% |
-
|
Nov 02
2020 |
SPOK
|
Todd J Stein |
BUY
Open market or private purchase
|
Indirect | 14,321 Added 1.26% |
$66,163
$4.62 p/Share
|
Nov 02
2020 |
SQ
|
Sivan Whiteley
Chief Legal Ofcr. & Corp. Sec. |
SELL
Open market or private sale
|
Direct | 2,938 Reduced 2.32% |
$464,204
$158.0 p/Share
|
Nov 02
2020 |
AMP
|
Robert Francis Sharpe Jr |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 16.18% |
$164,540
$164.54 p/Share
|
Nov 02
2020 |
MRNA
|
Stephane Bancel
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 8,893 Reduced 0.1% |
$604,902
$68.02 p/Share
|
Nov 02
2020 |
MRNA
|
Stephen Hoge
President |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 0.57% |
$680,200
$68.02 p/Share
|
Nov 02
2020 |
MRNA
|
Stephen Hoge
President |
BUY
Exercise of conversion of derivative security
|
Direct | 10,000 Added 0.56% |
$9,900
$0.99 p/Share
|
Nov 02
2020 |
MRNA
|
Tal Zvi Zaks
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 100.0% |
$1,012,350
$67.49 p/Share
|
Nov 02
2020 |
MRNA
|
Tal Zvi Zaks
Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 15,000 Added 50.0% |
$235,200
$15.68 p/Share
|
Nov 02
2020 |
NEM
|
John Kitlen
VP, Controller & CAO |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 5.3% |
$126,500
$63.25 p/Share
|
Nov 02
2020 |
NEM
|
Thomas Ronald Palmer
President & CEO |
SELL
Open market or private sale
|
Direct | 5,150 Reduced 2.0% |
$325,738
$63.25 p/Share
|
Nov 02
2020 |
NEM
|
Robert D Atkinson
EVP & COO |
SELL
Open market or private sale
|
Direct | 1,347 Reduced 1.53% |
$85,198
$63.25 p/Share
|
Nov 02
2020 |
BYND
|
Cari Soto
Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 55 Reduced 0.54% |
$7,896
$143.56 p/Share
|
Nov 02
2020 |
PAYS
|
Mark Kenneth Attinger |
SELL
Payment of exercise price or tax liability
|
Direct | 36,759 Reduced 25.73% |
$177,914
$4.84 p/Share
|
Nov 02
2020 |
PAYS
|
Robert Strobo
Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 13,639 Reduced 21.41% |
$66,013
$4.84 p/Share
|
Nov 02
2020 |
APRN
|
Dph Holdings LTD
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 107,535 Added 5.57% |
$466,702
$4.34 p/Share
|
Nov 02
2020 |
ANDE
|
John T Stout Jr
Director |
BUY
Other acquisition or disposition
|
Direct | 692 Added 2.01% |
$15,009
$21.69 p/Share
|
Nov 02
2020 |
BUDZ
|
Nicole M Breen
Secretary/Treasurer |
SELL
Open market or private sale
|
Indirect | 5,277 Reduced 0.02% |
$1,055
$0.2 p/Share
|
Nov 02
2020 |
BSY
|
Gregory S Bentley
Executive Chair & President |
BUY
Grant, award, or other acquisition
|
Direct | 11,073 Added 0.12% |
$396,192
$35.78 p/Share
|
Nov 02
2020 |
BSY
|
Keith A. Bentley
Director |
BUY
Grant, award, or other acquisition
|
Direct | 12,917 Added 0.08% |
$462,170
$35.78 p/Share
|
Nov 02
2020 |
EIDX
|
Cameron Turtle
Chief Business Officer |
SELL
Open market or private sale
|
Direct | 12,500 Reduced 16.02% |
$891,500
$71.32 p/Share
|
Nov 02
2020 |
EIDX
|
Cameron Turtle
Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 7,500 Added 8.77% |
$113,250
$15.1 p/Share
|
Nov 02
2020 |
UBI
|
Judith Ann Smith
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 200,000 Added 40.0% |
$62,000
$0.31 p/Share
|
Nov 02
2020 |
DRNA
|
James B Weissman
Chief Operating Officer & EVP |
SELL
Open market or private sale
|
Direct | 4,360 Reduced 12.04% |
$91,342
$20.95 p/Share
|
Nov 02
2020 |
DRNA
|
James B Weissman
Chief Operating Officer & EVP |
BUY
Exercise of conversion of derivative security
|
Direct | 4,360 Added 10.74% |
$14,911
$3.42 p/Share
|
Nov 02
2020 |
DRNA
|
Bob D Brown
Chief Scientific Ofr., EVP R&D |
SELL
Open market or private sale
|
Direct | 8,185 Reduced 23.59% |
$172,131
$21.03 p/Share
|
Nov 02
2020 |
DRNA
|
Bob D Brown
Chief Scientific Ofr., EVP R&D |
BUY
Exercise of conversion of derivative security
|
Direct | 8,185 Added 19.09% |
$27,993
$3.42 p/Share
|
Nov 02
2020 |
EPAY
|
Richard Douglas Booth
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 975 Reduced 0.89% |
$38,639
$39.63 p/Share
|
Nov 02
2020 |
EPAY
|
Robert A Eberle
President & CEO |
SELL
Open market or private sale
|
Direct | 2,557 Reduced 0.57% |
$101,334
$39.63 p/Share
|
Nov 02
2020 |
EPAY
|
Norman J Deluca
MD of Banking Solutions |
SELL
Open market or private sale
|
Direct | 854 Reduced 0.91% |
$33,844
$39.63 p/Share
|
Nov 02
2020 |
EPAY
|
John Francis Kelly
GM, Legal Solutions |
SELL
Open market or private sale
|
Direct | 413 Reduced 0.67% |
$16,367
$39.63 p/Share
|
Nov 02
2020 |